Clinical Trial

Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder

Name: Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder — clinical trial record (NCT02129751)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety

Protocol Amendment History 9 amendments

This ClinicalTrials.gov record has been amended 9 times since 2014-05-01; most recent amendment 2025-09-11.

Trial Details

NCT Number	NCT02129751
Lead Sponsor	Bausch Health Americas, Inc.
Conditions	Major Depressive Disorder
Enrollment	246 participants
Start Date	2026-06
Primary Completion	2029-07 (estimated)
Study Completion	2029-12 (estimated)
Updated on ClinicalTrials.gov	2025-09-17